Guliyev, M. (2025) “Evaluating the Prognostic Role of Pan-Immune-Inflammation Value in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab”, Cerrahpaşa Medical Journal, 49(1), pp. 1–9. doi: 10.5152/cjm.2025.25038.